Diagnosis of Early Pancreas Graft Failure via Antibody‐Mediated Rejection: Single‐Center Experience With 256 Pancreas Transplantations

Early pancreas graft loss is usually attributed to technical failure while the possibility of antibody‐mediated rejection (AMR) is generally overlooked. To investigate the role of AMR in early pancreas graft loss, we retrospectively assessed 256 patients with simultaneous pancreas–kidney transplanta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2014-04, Vol.14 (4), p.936-942
Hauptverfasser: de Kort, H., Mallat, M. J. K., van Kooten, C., de Heer, E., Brand‐Schaaf, S. H., van der Wal, A. M., Roufosse, C., Roelen, D. L., Bruijn, J. A., Claas, F. H., de Fijter, J. W., Bajema, I. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Early pancreas graft loss is usually attributed to technical failure while the possibility of antibody‐mediated rejection (AMR) is generally overlooked. To investigate the role of AMR in early pancreas graft loss, we retrospectively assessed 256 patients with simultaneous pancreas–kidney transplantation (SPK) between 1985 and 2010 at our institute. We included 33 SPK patients who lost their pancreas graft 1 month after transplantation in 6/7 cases, whereas all other causes typically led to loss
ISSN:1600-6135
1600-6143
DOI:10.1111/ajt.12624